eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


Indexed in:

Web of Science
Clarivate Analytics

Journal Citation Indicator
CiteScore 2021
Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.

Indexed in PubMed and Web of Science Core Collection
vol. 8
the latest issue:

Review paper

The effects of seaweed supplementation consumption for improvement of liver injury in patients with non-alcoholic fatty liver disease: a systematic review

Muhammad Luthfi Adnan, Miranti Dewi Pramaningtyas
Clin Exp HEPATOL 2022; 8, 3: 171-177
Online publish date: 2022-08-04
DOI: https://doi.org/10.5114/ceh.2022.118275
Original paper

Dextromethorphan improves locomotor activity and decreases brain oxidative stress and inflammation in an animal model of acute liver failure

Mohammad Mehdi Ommati, Akram Jamshidzadeh, Mohsen Saeed, Mohammad Rezaei, Reza Heidari
Clin Exp HEPATOL 2022; 8, 3: 178-187
Online publish date: 2022-08-03
DOI: https://doi.org/10.5114/ceh.2022.118299
Original paper

Association between hypothyroidism and liver fibrosis risk: a systematic review and meta-analysis

Adinda Ayu Dyah Rahadini, Adinda Rahadina
Clin Exp HEPATOL 2022; 8, 3: 188-194
Online publish date: 2022-09-26
DOI: https://doi.org/10.5114/ceh.2022.118594
Original paper

Cellular and mitochondrial taurine depletion in bile duct ligated rats: a justification for taurine supplementation in cholestasis/cirrhosis

Asma Najibi, Heresh Rezaei, Ram Kumar Manthari, Hossein Niknahad, Akram Jamshidzadeh, Omid Farshad, Feng Yan, Yanqin Ma, Dongmei Xu, Zhongwei Tang, Mohammad Mehdi Ommati, Reza Heidari
Clin Exp HEPATOL 2022; 8, 3: 195-210
Online publish date: 2022-09-21
DOI: https://doi.org/10.5114/ceh.2022.119216
Original paper

The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients

Gamal Y. S. Raia, Eman Abdelsameea, Dalia Hamdy Twfic Taie, Omar Elshaarawy, Noha Rabie Bayomy, Rasha G Mostafa, Aml Abd Alhamid Alsharnoby, Karema Abdelhady Diab
Clin Exp HEPATOL 2022; 8, 3: 211-218
Online publish date: 2022-09-15
DOI: https://doi.org/10.5114/ceh.2022.119265
Original paper

Outcomes of endoscopic retrograde cholangio-pancreatography in patients with liver transplant

Tsujung Yang, Achint Patel, Rishita Pujari, Vincent P. Okine, Lakshmi G. Chirumamilla, Geethu Jnaneswaran, Athul Raj, Keji L. Kwajok, Ruchir Goswami, Prakashkumar Maiyani, Maheshkumar Desai, Hardikkumar Shah, Matthew Grossman
Clin Exp HEPATOL 2022; 8, 3: 226-232
Online publish date: 2022-09-14
DOI: https://doi.org/10.5114/ceh.2022.119246
Original paper

Significance of altered anticoagulant proteins and D-dimer in cirrhotic portal vein thrombosis: relation to the degree of liver dysfunction

Marwa Metawea, Doaa El Wazzan, Assem El-Shendidi
Clin Exp HEPATOL 2022; 8, 3: 233-242
Online publish date: 2022-09-19
DOI: https://doi.org/10.5114/ceh.2022.119308
Original paper

Diagnostic performance of RASSF1A and CDKN2A gene methylation versus a-fetoprotein in hepatocellular carcinoma

Hanan Mohamed Nomeir, Heba Gaber El-Sheredy, Azhar Mohamed Nomeir, Neveen Rashad Mostafa, Shaymaa Ali El-hamshary
Clin Exp HEPATOL 2022; 8, 3: 243-252
Online publish date: 2022-09-16
DOI: https://doi.org/10.5114/ceh.2022.119315
Letter to the Editor

Seroprevalence of hepatitis A antibodies in patients with cirrhosis of liver

Mayank Jain
Clin Exp HEPATOL 2022; 8, 3: 253-254
Online publish date: 2022-09-08
DOI: https://doi.org/10.5114/ceh.2022.118225
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.